A clade C HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaques
Author(s) -
Anusmita Sahoo,
Andrew Jones,
Narayanaiah Cheedarla,
Sailaja Gangadhara,
Vicky Roy,
Tiffany M. Styles,
Ayalnesh Shiferaw,
Korey A. Walter,
LaTonya D. Williams,
Xiaoying Shen,
Gabriel Ozorowski,
Wen-Hsin Lee,
Samantha L. Burton,
Yi Lasanajak,
Xuezheng Song,
Zhaohui Qin,
Cynthia A. Derdeyn,
Andrew B. Ward,
John D. Clements,
Raghavan Varadarajan,
Georgia D. Tomaras,
Pamela A. Kozlowski,
Galit Alter,
Rama Rao Amara
Publication year - 2022
Publication title -
science immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 8.83
H-Index - 51
ISSN - 2470-9468
DOI - 10.1126/sciimmunol.abl4102
Subject(s) - modified vaccinia ankara , heterologous , biology , virology , vaccination , cd8 , immunology , hiv vaccine , vaccinia , antibody , elispot , glycosylation , immune system , cytotoxic t cell , recombinant dna , vaccine trial , in vitro , gene , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom